Guidance for reporting outcomes in clinical trials: scoping review protocol

被引:10
|
作者
Butcher, Nancy J. [1 ]
Mew, Emma J. [1 ]
Saeed, Leena [1 ]
Monsour, Andrea [1 ]
Chee-a-Tow, Alyssandra [1 ]
Chan, An-Wen [2 ]
Moher, David [3 ]
Offringa, Martin [1 ]
机构
[1] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Med, Womens Coll Res Inst, Womens Coll Hosp, Toronto, ON, Canada
[3] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Toronto, ON, Canada
来源
BMJ OPEN | 2019年 / 9卷 / 02期
基金
加拿大健康研究院;
关键词
RANDOMIZED-TRIALS;
D O I
10.1136/bmjopen-2018-023001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Patients, families and clinicians rely on published research to help inform treatment decisions. Without complete reporting of the outcomes studied, evidence-based clinical and policy decisions are limited and researchers cannot synthesise, replicate or build on existing research findings. To facilitate harmonised reporting of outcomes in published trial protocols and reports, the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT) is under development. As one of the initial steps in the development of InsPECT, a scoping review will identify and synthesise existing guidance on the reporting of trial outcomes. Methods and analysis We will apply methods based on the Joanna Briggs Institute scoping review methods manual. Documents that provide explicit guidance on trial outcome reporting will be searched for using: (1) an electronic bibliographic database search; (2) a grey literature search; and (3) solicitation of colleagues for guidance documents using a snowballing approach. Reference list screening will be performed for included documents. Search results will be divided between two trained reviewers who will complete title and abstract screening, full-text screening and data charting. Captured trial outcome reporting guidance will be compared with candidate InsPECT items to support, refute or refine InsPECT content and to assess the need for the development of additional items. Data analysis will explore common features of guidance and use quantitative measures (eg, frequencies) to characterise guidance and its sources. Ethics and dissemination A paper describing the review findings will be published in a peer-reviewed journal. The results will be used to inform the InsPECT development process, helping to ensure that InsPECT provides an evidence-based tool for standardising trial outcome reporting.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review
    Luo, Hao
    Schumacher, Oliver
    Galvao, Daniel A.
    Newton, Robert U.
    Taaffe, Dennis R.
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [2] Guidance relevant to the reporting of health equity in observational research: a scoping review protocol
    Rizvi, Anita
    Lawson, Daeria O.
    Young, Taryn
    Dewidar, Omar
    Nicholls, Stuart
    Akl, Elie A.
    Little, Julian
    Magwood, Olivia
    Shamseer, Larissa
    Ghogomu, Elizabeth
    Jull, Janet Elizabeth
    Rader, Tamara
    Bhutta, Zulfiqar
    Chamberlain, Catherine
    Ellingwood, Holly
    Greer-Smith, Regina
    Hardy, Billie-Jo
    Harwood, Matire
    Kennedy, Michelle
    Kredo, Tamara
    Loder, Elizabeth
    Mahande, Michael Johnson J.
    Mbuagbaw, Lawrence
    Nkangu, Miriam
    Okwen, Patrick M.
    Ramke, Jacqueline
    Tufte, Janice
    Tugwell, Peter
    Wang, Xiaoqin
    Wiysonge, Charles Shey
    Welch, Vivian A.
    [J]. BMJ OPEN, 2022, 12 (05):
  • [3] Reporting of Tobacco Use and Impact on Outcomes in Cancer Cooperative Group Clinical Trials: A Systematic Scoping Review
    Eng, L.
    Brual, J.
    Nagee, A.
    Mok, S.
    Fazelzad, R.
    Chaiton, M.
    Saunders, D.
    Mittmann, N.
    Truscott, R.
    Liu, G.
    Bradbury, P.
    Evans, W. K.
    Papadakos, J.
    Giuliani, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S123 - S124
  • [4] Reporting of tobacco use and impact on outcomes in cancer cooperative group clinical trials: A systematic scoping review
    Eng, Lawson
    Brual, Janette
    Nagee, Ahsas
    Mok, Spencer
    Fazelzad, Rouhi
    Truscott, Rebecca
    Mittmann, Nicole
    Chaiton, Michael
    Saunders, Deborah
    Liu, Geoffrey
    Bradbury, Penelope Ann
    Evans, William K.
    Papadakos, Janet
    Giuliani, Meredith Elana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [5] Reporting time toxicity in prospective cancer clinical trials: A scoping review
    Quinn, Patrick L.
    Saiyed, Shah
    Hannon, Connor
    Sarna, Angela
    Waterman, Brittany L.
    Cloyd, Jordan M.
    Spriggs, Rodney
    Rush, Laura J.
    McAlearney, Ann Scheck
    Ejaz, Aslam
    [J]. SUPPORTIVE CARE IN CANCER, 2024, 32 (05) : 275
  • [6] Adaptive clinical trials in surgery: A scoping review of methodological and reporting quality
    Staibano, Phillip
    Oulousian, Emily
    McKechnie, Tyler
    Thabane, Alex
    Luo, Samuel
    Gupta, Michael K.
    Zhang, Han
    Pasternak, Jesse D.
    Au, Michael
    Parpia, Sameer
    Young, J. E. M.
    Bhandari, Mohit
    [J]. PLOS ONE, 2024, 19 (05):
  • [7] Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review
    Manyara, Anthony Muchai
    Davies, Philippa
    Stewart, Derek
    Weir, Christopher J.
    Young, Amber E.
    Wells, Valerie
    Blazeby, Jane
    Butcher, Nancy J.
    Bujkiewicz, Sylwia
    Chan, An-Wen
    Collins, Gary S.
    Dawoud, Dalia
    Offringa, Martin
    Ouwens, Mario
    Ross, Joseph S.
    Taylor, Rod S.
    Ciani, Oriana
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 160 : 83 - 99
  • [8] Reporting and analysis of process-of-care time measures in clinical trials for hyperacute stroke interventions: a scoping review protocol
    Italiano, Dominic
    Johns, Hannah
    Campbell, Bruce
    Turc, Guillaume
    Churilov, Leonid
    [J]. JBI EVIDENCE SYNTHESIS, 2024, 22 (03) : 489 - 497
  • [9] Evidence on reporting guidelines for surgical technique in clinical disciplines: a scoping review protocol
    Zhang, Kaiping
    Ma, Yanfang
    Shi, Qianling
    Shen, Jianfei
    Wu, Jinlin
    Zhang, Xianzhuo
    Jiao, Panpan
    Li, Grace S.
    Tang, Xueqin
    Petersen, Rene Horsleben
    Ng, Calvin S. H.
    Fiorelli, Alfonso
    Novoa, Nuria M.
    Bedetti, Benedetta
    Sandri, Giovanni Battista Levi
    Hochwald, Steven
    Lerut, Toni
    Sihoe, Alan D. L.
    Barchi, Leandro Cardoso
    Gilbert, Sebastien
    Waseda, Ryuichi
    Toker, Alper
    Gonzalez-Rivas, Diego
    Fruscio, Robert
    Scarci, Marco
    Davoli, Fabio
    Piessen, Guillaume
    Qiu, Bin
    Wang, Stephen
    Chen, Yaolong
    Gao, Shugeng
    [J]. GLAND SURGERY, 2021, 10 (07) : 2325 - 2333
  • [10] Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review
    Chris J. Selman
    Katherine J. Lee
    Clare L. Whitehead
    Brett J. Manley
    Robert K. Mahar
    [J]. Trials, 24